4 High-CBD Cannabis Strains: What to Know Before Choosing

A closer look at four cannabis cultivars commonly associated with CBD-dominant profiles

Charlotte's Web, Suzy Q, Harlequin, and ACDC are commonly described as high-CBD cannabis strains. However, a strain name does not guarantee a particular CBD-to-THC ratio or a predictable effect. Check the current product label and certificate of analysis, when available, before choosing any cannabis flower.

Cannabis products sold under the same strain name can differ in their cannabinoid and terpene profiles. Research into commercial cannabis has found that common labels do not always align neatly with a product's measured chemistry. For consumers, the laboratory results for the specific batch are usually more useful than the name alone. You can learn more about why strain labels do not always predict effects in our related True Blue guide.

What is CBD?
Cannabidiol, better known as CBD, is one of the best-known cannabinoids found in cannabis and hemp. Unlike THC, CBD does not usually produce the intoxicating high associated with cannabis. That does not mean every CBD-containing product is non-intoxicating. High-CBD flower may still contain THC, and the amount can vary by batch.

The strongest established medical evidence applies to a purified prescription CBD medicine used under medical supervision for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. This is not the same as smoking or vaporizing a CBD-dominant cannabis strain.

Research into cannabis and cannabinoids for pain, anxiety, inflammation, sleep, PTSD, and other conditions is still developing. Findings vary by condition, dose, formulation, and study quality. Evidence involving a prescription medicine, a combined THC-CBD product, or a laboratory study should not automatically be applied to CBD-dominant flower. See what researchers currently know about cannabis and cannabinoids and our broader guide to CBD research for more context.

How is CBD different from THC?
THC is the primary intoxicating cannabinoid in many cannabis products. It can affect coordination, reaction time, memory, judgment, and perception. CBD does not normally cause the same type of high, but it can still affect alertness and interact with some medications.

CBD should not be assumed to cancel out THC or prevent anxiety, impairment, or other unwanted effects. The response to a product depends on its cannabinoid content, dose, method of use, and the individual.

You may also hear about the entourage effect. This is the hypothesis that cannabinoids, terpenes, and other cannabis compounds may influence one another. It is a useful research concept, but current evidence does not support the claim that a particular terpene or strain combination guarantees health outcomes.

A strain name is a starting point. Current batch testing provides more useful information about CBD and THC content.

The following cultivars are widely associated with CBD-forward cannabis. Availability and composition vary by producer and location, so these profiles should be treated as general descriptions rather than medical recommendations.

Charlotte's Web
Charlotte's Web became nationally known through media coverage of Charlotte Figi, a child with Dravet syndrome who used a CBD-rich preparation. That history helped bring public attention to CBD, but it does not prove that every flower, extract, or consumer product sold under the Charlotte's Web name can treat seizures or another health condition.

Products using this name are generally marketed as CBD dominant with relatively little THC. Check the product's cannabinoid results because the composition and legal classification may differ among producers.

Suzy Q
Suzy Q is commonly marketed as a CBD-dominant cultivar and is often described as having earthy, pine-like, or herbal aroma notes. Claims that it reliably increases focus, creativity, or productivity are mostly anecdotal and should not be treated as established effects.

Before buying, compare the listed CBD and THC levels rather than relying on the name or a dispensary description. Aroma and perceived effects can also vary from one batch to another.

Harlequin
Harlequin is often sold as a CBD-forward or balanced cultivar. Some descriptions associate it with a specific CBD-to-THC ratio, but that ratio is not guaranteed. One producer's Harlequin may contain substantially different cannabinoid levels from another producer's version.

Because Harlequin may contain meaningful amounts of THC, it can still cause intoxication or impairment. Do not rely on its CBD-forward reputation when deciding whether it is safe to drive, operate machinery, or comply with workplace drug-testing requirements.

ACDC
ACDC is another cultivar commonly marketed with more CBD than THC. It is sometimes described as a beginner-friendly option, but that description can be misleading. Individual sensitivity varies, and even a CBD-dominant batch may contain enough THC to cause unwanted effects or contribute to a positive drug test.

Review the product's laboratory results and use only where permitted by local law. ACDC should not be presented as providing all the benefits of cannabis without risks or side effects.

Other names commonly associated with CBD-forward cannabis include Sweet & Sour Widow, Ringo's Gift, and Remedy. As with the four cultivars above, the name alone cannot confirm potency, purity, safety, or a particular experience.

Review the cannabinoid results.
Check the CBD, THC, THCA, and total THC information for the specific batch. A product described as CBD dominant is not necessarily THC-free.

Look for independent testing.
Use products that provide recent laboratory results from a qualified third-party laboratory. The report should identify the tested batch and, where required or available, include screening for pesticides, heavy metals, microbes, solvents, and other contaminants.

Do not treat a strain as medicine.
A high-CBD cultivar is not equivalent to an FDA-approved prescription CBD product. Do not use cannabis flower as a replacement for prescribed treatment or delay professional care for pain, anxiety, seizures, cancer, PTSD, or another health condition.

Consider medications and side effects.
CBD can interact with some medicines and may cause changes in alertness, digestive symptoms, appetite changes, or mood changes. The FDA also identifies potential liver-related risks with CBD exposure. Discuss cannabis or CBD use with a qualified healthcare professional, especially when taking prescription medicines.

Plan for possible impairment and drug testing.
High-CBD flower may contain THC. Do not drive or operate machinery after using a product that could impair you. The CDC also warns that inaccurate CBD labeling or higher-than-stated THC content could contribute to a positive workplace drug test. Read more about CBD products and workplace drug testing.

Take extra precautions during pregnancy and breastfeeding.
People who are pregnant, planning a pregnancy, or breastfeeding should speak with a healthcare professional and review current medical guidance before using cannabis or CBD products.

Keep cannabis away from children and pets.
The FDA has not approved cannabis or CBD for use in animals and advises pet owners to consult a veterinarian. Store all cannabis products securely to prevent accidental ingestion.

Check the law where you live.
Cannabis and hemp rules vary by country, state, and locality. Product legality may depend on its THC concentration, format, intended use, and where it is sold. Confirm current local requirements before buying, possessing, or traveling with a product.

High-CBD strain names can help narrow a search, but they should not be treated as guarantees. Current laboratory results, clear labeling, responsible use, and appropriate professional advice provide a more reliable basis for choosing a product.

This article is for general educational purposes and is not medical, veterinary, or legal advice.